Striverdi Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for daily maintenance of bronchospasms in chronic obstructive pulmonary disease (COPD). Striverdi Respimat is not indicated for acute attacks. Striverdi Respimat is also known by its drug name, Olodaterol.

Striverdi Respimat is a bronchodilator, a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Striverdi Respimat is believed to work by relaxing smooth muscles in the airways. Striverdi Respimat is considered a long-acting bronchodilator.

How do I take it?
Striverdi Respimat comes as an inhaler. Two sprays of Striverd... read more

Striverdi Respimat (Olodaterol) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in